Facts & Figures
Are you up to date?
See you in Vienna.
See you in Vienna.
News
Valneva Reports Positive Results for Phase 1 Trial of Second Generation Zika Vaccine Candidate
Immune response successfully improved with second generation vaccine candidate
UpNano: From Nanometers to Industry: High-Resolution 2PP 3D Printing Now in China
Collaboration between UpNano and Husun Technologies brings high-resolution 2PP 3D-printing to one of the world’s largest…
Hookipa Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead
Hookipa Pharma Inc. (OTCID: HOOK, “HOOKIPA”) today announced the completion of the sale of its assets related to…
Driven by curiosity, inspired by our city...
Open Calls and Deadlines
Events
Vienna
IMP: 40 Years of Finding Out
On Wednesday, 5 November 2025, the IMP will mark its 40th anniversary with a one-day symposium that brings together past…
Wien, online
Pharmig Academy: Pharmakovigilanz Zertifikatslehrgang – Arzneimittelsicherheit von A bis Z, Modul 4
Safety Assessment
Vienna
22nd Vienna Biocenter PhD Symposium: Bringing it all back Home - Vienna BioCenter Alumni reunion
The symposium will be an opportunity to connect the current members and alumni of the Vienna BioCenter through our…
Wien, online
Pharmig Academy: Qualitätsmanagement & GxP: Kompetent handeln im regulatorischen Umfeld - Modul 4
GDP & Logistik: Sichere Lagerung und Distribution in der pharmazeutischen Supply Chain